Nicholas Kendall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicholas Kendall has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Abdelrahman M. Hamouda
Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA
3 shared publications - Rahul Kumar
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA
3 shared publications - Ahmad Nassr
Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN
2 shared publications - Alexandra R. Paul
Department of Neurosurgery, Albany Medical Center, Albany, New York, USA
2 shared publications - Anthony Loren Mikula
Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA
2 shared publications - Arjun S. Sebastian
Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN
2 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (12) , 7002-7006
MRI detection of delayed intracranial germinoma relapse presenting as leptomeningeal seeding along multiple cranial nerves: A case report
- 18 November 2026
- Published by Elsevier in Radiology Case Reports
- Vol. 21 (12) , 7002-7006
Open AccessMRI detection of delayed intracranial germinoma relapse presenting as leptomeningeal seeding along multiple cranial nerves: A case report
- 25 September 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Comparative Efficacy of Embolic Agents for Single-Session Meningeal Artery Embolization and Surgical Evacuation: Evaluating Liquids, Particles, and Adjunct Coils
BACKGROUND AND OBJECTIVES: Single-session middle meningeal artery embolization (MMAE) combined with surgical evacuation is an emerging strategy for management of patients with chronic subdural hematoma (cSDH). However, comparative outcome data based on embolic material selection in this setting remain limited. We compared clinical, radiographic, and functional outcomes of patients treated with cSDH using liquid or particle embolic agents and evaluated the effect of adjunctive coil use. METHODS: We conducted a retrospective multicenter cohort study of consecutive adults undergoing single-session MMAE with surgical evacuation for cSDH. Outcomes were compared by embolic material (liquid vs particle) using 1:1 propensity score matching. The impact of adjunctive coiling was assessed in the overall cohort. Associations were evaluated using multivariable logistic regression and reported as odds ratios with 95% CIs. RESULTS: Among 268 identified patients, 100 (50 liquid and 50 particle) were propensity-score matched for analysis. Rates of improved or stable functional status at last follow-up were similar between liquid (79.2%) and particle embolization (72.5%) groups ( P = .701), as were ≥50% hematoma reduction (66.0% vs 72.0%, P = .464), postoperative complications (6.0% vs 8.0%, P = .672), and all-cause mortality (14.0% vs 14.0%, P = .951). Particle embolization was associated with a higher rate of needing any re-evacuation (20.0% vs 6.0%; adjusted odds ratio 5.13, 95% CI = 1.12-23.42, P = .035). Adjunct coiling lengthened procedure duration (203 [187-269] vs 198 [163-232] minutes, P = .019) without significant differences in clinical, radiographic, or adverse outcomes. CONCLUSION: In patients undergoing single-session MMAE with surgical evacuation for cSDH, liquid and particle embolic agents demonstrated comparable safety and functional and radiographic efficacy. However, liquid embolization was associated with significantly fewer reinterventions. Adjunctive coiling lengthened procedural time without differences in clinical or radiographic outcomes. Prospective comparative studies are needed to further define the role of embolic material and technical factors in patients undergoing evacuation and MMAE.
- 25 September 2026
- Published by Wolters Kluwer Health in Operative Neurosurgery
Comparative Efficacy of Embolic Agents for Single-Session Meningeal Artery Embolization and Surgical Evacuation: Evaluating Liquids, Particles, and Adjunct Coils
BACKGROUND AND OBJECTIVES: Single-session middle meningeal artery embolization (MMAE) combined with surgical evacuation is an emerging strategy for management of patients with chronic subdural hematoma (cSDH). However, comparative outcome data based on embolic material selection in this setting remain limited. We compared clinical, radiographic, and functional outcomes of patients treated with cSDH using liquid or particle embolic agents and evaluated the effect of adjunctive coil use. METHODS: We conducted a retrospective multicenter cohort study of consecutive adults undergoing single-session MMAE with surgical evacuation for cSDH. Outcomes were compared by embolic material (liquid vs particle) using 1:1 propensity score matching. The impact of adjunctive coiling was assessed in the overall cohort. Associations were evaluated using multivariable logistic regression and reported as odds ratios with 95% CIs. RESULTS: Among 268 identified patients, 100 (50 liquid and 50 particle) were propensity-score matched for analysis. Rates of improved or stable functional status at last follow-up were similar between liquid (79.2%) and particle embolization (72.5%) groups ( P = .701), as were ≥50% hematoma reduction (66.0% vs 72.0%, P = .464), postoperative complications (6.0% vs 8.0%, P = .672), and all-cause mortality (14.0% vs 14.0%, P = .951). Particle embolization was associated with a higher rate of needing any re-evacuation (20.0% vs 6.0%; adjusted odds ratio 5.13, 95% CI = 1.12-23.42, P = .035). Adjunct coiling lengthened procedure duration (203 [187-269] vs 198 [163-232] minutes, P = .019) without significant differences in clinical, radiographic, or adverse outcomes. CONCLUSION: In patients undergoing single-session MMAE with surgical evacuation for cSDH, liquid and particle embolic agents demonstrated comparable safety and functional and radiographic efficacy. However, liquid embolization was associated with significantly fewer reinterventions. Adjunctive coiling lengthened procedural time without differences in clinical or radiographic outcomes. Prospective comparative studies are needed to further define the role of embolic material and technical factors in patients undergoing evacuation and MMAE.
- 19 March 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 177 (2) , 63
Lower-grade glioma imaging volumes and survival: a single-institution analysis of 90 patients after resection using intraoperative MRI
Purpose Extent of resection (EOR) and residual tumor volume (RTV) are key prognostic factors in lower-grade gliomas (LGGs). Intraoperative magnetic resonance imaging (iMRI) enables real-time assessment of tumor removal, but the survival relevance of sequential volumetric measures remains incompletely defined. This study evaluated the relationship between T2- and FLAIR-based imaging volumes, EOR, and survival in patients undergoing LGG resection with iMRI with long-term radiographic and clinical follow-up. Methods We retrospectively reviewed 90 patients with WHO Grade 2–3 LGGs who underwent iMRI-guided resection between 2011 and 2023 at a single institution. Radiographic and clinical follow-up was tracked through 2025. Volumetric analyses were performed on preoperative, intraoperative, immediate postoperative, and three-month postoperative T2-weighted and FLAIR sequences. Associations between imaging volumes, EOR, and progression-free (PFS), malignant progression-free (mPFS), and overall (OS) survival were assessed using log-rank and multivariable Cox regression analyses, including subgroup analysis by isocitrate dehydrogenase (IDH) mutation status. Results Median clinical and radiographic follow-up was 94.5 ± 34.8 months. Greater EOR correlated with longer survival across all metrics. In IDH-mutant tumors, FLAIR-based EOR was independently predictive of PFS (p ≤ 0.03), mPFS (p ≤ 0.02), and OS (p ≤ 0.02) on multivariable analysis. Additional resection after iMRI occurred in 55.6% of patients, with 90% yielding positive tumor margins, but did not independently improve survival. Conclusion In LGG surgery accompanied by iMRI, greater EOR and smaller residual T2/FLAIR volumes predict longer survival, particularly among IDH-mutant tumors. The use of iMRI facilitates maximal safe resection.
- 19 March 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 177 (2) , 63
Lower-grade glioma imaging volumes and survival: a single-institution analysis of 90 patients after resection using intraoperative MRI
Purpose Extent of resection (EOR) and residual tumor volume (RTV) are key prognostic factors in lower-grade gliomas (LGGs). Intraoperative magnetic resonance imaging (iMRI) enables real-time assessment of tumor removal, but the survival relevance of sequential volumetric measures remains incompletely defined. This study evaluated the relationship between T2- and FLAIR-based imaging volumes, EOR, and survival in patients undergoing LGG resection with iMRI with long-term radiographic and clinical follow-up. Methods We retrospectively reviewed 90 patients with WHO Grade 2–3 LGGs who underwent iMRI-guided resection between 2011 and 2023 at a single institution. Radiographic and clinical follow-up was tracked through 2025. Volumetric analyses were performed on preoperative, intraoperative, immediate postoperative, and three-month postoperative T2-weighted and FLAIR sequences. Associations between imaging volumes, EOR, and progression-free (PFS), malignant progression-free (mPFS), and overall (OS) survival were assessed using log-rank and multivariable Cox regression analyses, including subgroup analysis by isocitrate dehydrogenase (IDH) mutation status. Results Median clinical and radiographic follow-up was 94.5 ± 34.8 months. Greater EOR correlated with longer survival across all metrics. In IDH-mutant tumors, FLAIR-based EOR was independently predictive of PFS (p ≤ 0.03), mPFS (p ≤ 0.02), and OS (p ≤ 0.02) on multivariable analysis. Additional resection after iMRI occurred in 55.6% of patients, with 90% yielding positive tumor margins, but did not independently improve survival. Conclusion In LGG surgery accompanied by iMRI, greater EOR and smaller residual T2/FLAIR volumes predict longer survival, particularly among IDH-mutant tumors. The use of iMRI facilitates maximal safe resection.
- 29 December 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
Achieving Alignment and Implant-Specific Goals in Anterior Lumbar Interbody Fusion, and Predictors of Postoperative Intradiscal Lordosis: The Role of Spinopelvic Parameters, Cage Lordosis, Intraoperative Consistency, Surgical Technique, and Treated Level
BACKGROUND AND OBJECTIVES: Anterior lumbar interbody fusion (ALIF) is a powerful procedure for sagittal correction and indirect decompression in the lumbar spine, though aggressive correction can cause stretch neuropraxia and implant subsidence. The aim of this study was to identify radiographic and clinical predictors of segmental correction, as well as to evaluate the degree to which segmental correction on supine intraoperative radiographs translates to postoperative upright alignment changes. METHODS: We identified patients treated with 1- or 2-level ALIF at a tertiary care center and extracted data on demographics, spinopelvic parameters, and surgical details. Patients treated with isolated ALIF and ALIF with supplementary posterior instrumentation were compared on pre- and postoperative intradiscal lordosis (IDL) and change in IDL. Multivariable linear regression was performed to identify independent predictors of postoperative IDL. RESULTS: We included 204 patients (median age 57 years, 55.4% male) treated at 258 levels, of whom 114 (55.9%) underwent supplementary posterior fixation and 150 (73.5%) underwent single-level implantation. Across all patients, postoperative IDL was significantly greater than preoperative segmental lordosis (25.4° vs 15.3°; P < .001). Standalone ALIF achieved less ΔIDL than circumferential fusion for L5/S1 procedures (7.4° vs 11.6°; P < .001), though ΔIDL for L3/4 and L4/5 was similar between the standalone and circumferential groups. Multivariable analysis showed postoperative IDL to be predicted by greater preoperative IDL (β = 0.26° per degree; [0.15, 0.36]; P < .001), L5/S1 [vs L4/5] implantation (β = 3.97°; [2.72, 5.21]; P < .001), use of supplementary posterior fixation (β = 1.80°; [0.70, 2.89]; P < .001), and greater implant lordosis (β = 0.62° per degree; [0.44, 0.79]; P < .001). CONCLUSION: Postoperative IDL after 1- or 2-level ALIF is best predicted by placement of larger interbody sizes, L5/S1 implantation, greater baseline IDL, and use of adjunct posterior fixation. Patients with higher preoperative lordosis experienced smaller postoperative increases in IDL, though this was likely influenced by a treatment bias.
- 29 December 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
Achieving Alignment and Implant-Specific Goals in Anterior Lumbar Interbody Fusion, and Predictors of Postoperative Intradiscal Lordosis: The Role of Spinopelvic Parameters, Cage Lordosis, Intraoperative Consistency, Surgical Technique, and Treated Level
BACKGROUND AND OBJECTIVES: Anterior lumbar interbody fusion (ALIF) is a powerful procedure for sagittal correction and indirect decompression in the lumbar spine, though aggressive correction can cause stretch neuropraxia and implant subsidence. The aim of this study was to identify radiographic and clinical predictors of segmental correction, as well as to evaluate the degree to which segmental correction on supine intraoperative radiographs translates to postoperative upright alignment changes. METHODS: We identified patients treated with 1- or 2-level ALIF at a tertiary care center and extracted data on demographics, spinopelvic parameters, and surgical details. Patients treated with isolated ALIF and ALIF with supplementary posterior instrumentation were compared on pre- and postoperative intradiscal lordosis (IDL) and change in IDL. Multivariable linear regression was performed to identify independent predictors of postoperative IDL. RESULTS: We included 204 patients (median age 57 years, 55.4% male) treated at 258 levels, of whom 114 (55.9%) underwent supplementary posterior fixation and 150 (73.5%) underwent single-level implantation. Across all patients, postoperative IDL was significantly greater than preoperative segmental lordosis (25.4° vs 15.3°; P < .001). Standalone ALIF achieved less ΔIDL than circumferential fusion for L5/S1 procedures (7.4° vs 11.6°; P < .001), though ΔIDL for L3/4 and L4/5 was similar between the standalone and circumferential groups. Multivariable analysis showed postoperative IDL to be predicted by greater preoperative IDL (β = 0.26° per degree; [0.15, 0.36]; P < .001), L5/S1 [vs L4/5] implantation (β = 3.97°; [2.72, 5.21]; P < .001), use of supplementary posterior fixation (β = 1.80°; [0.70, 2.89]; P < .001), and greater implant lordosis (β = 0.62° per degree; [0.44, 0.79]; P < .001). CONCLUSION: Postoperative IDL after 1- or 2-level ALIF is best predicted by placement of larger interbody sizes, L5/S1 implantation, greater baseline IDL, and use of adjunct posterior fixation. Patients with higher preoperative lordosis experienced smaller postoperative increases in IDL, though this was likely influenced by a treatment bias.
- 31 October 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (11) , 2093-2102
Outcomes of combined mechanical thrombectomy versus stent retriever or contact aspiration in acute ischemic stroke: an updated network meta-analysis
Background For large vessel occlusion (LVO) ischemic strokes, three major techniques of mechanical thrombectomy (MT) have demonstrated efficacy. Here we compare the safety and efficacy of stent retrievers (SR), contact aspiration (Asp), and a combined mechanical thrombectomy (cMT) for LVO ischemic stroke. Methods Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we queried the PubMed, EMBASE, Scopus, and Web of Science databases for studies published prior to December 2024 describing patients with ischemic stroke who underwent MT using SR, Asp, or cMT. Results Twnety-four studies comprising a total of 12 845 patients were included in the analysis. Compared with cMT, Asp was associated with a lower rate of first pass effect (FPE) (risk ratio (RR) 0.67; 95% CI 0.46 to 0.96), shorter procedure duration (mean difference (MD) −13.35 min; 95% CI −20.83 to –5.87), and lower risk of arterial dissection (RR 0.50; 95% CI 0.29 to 0.87). Additionally, SR use was linked to a higher procedure duration compared with Asp (MD 13.39 min; 95% CI 5.55 to 21.22) and a lower symptomatic intracranial hemorrhage rate (RR 0.75; 95% CI 0.59 to 0.96). No significant differences were observed between groups in terms of number of passes, successful recanalization, 90-day functional outcomes, mortality, arterial perforation, or embolization to new territory. Conclusions All three techniques demonstrated similar recanalization rates and functional outcomes. However, Asp was associated with shorter procedure times and fewer arterial dissection complications, while cMT showed a higher FPE. Given the comparable overall efficacy, the choice of technique should be guided by the physician’s preference, expertise, and confidence, tailored to the individual patient’s profile.
- 31 October 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (11) , 2093-2102
Outcomes of combined mechanical thrombectomy versus stent retriever or contact aspiration in acute ischemic stroke: an updated network meta-analysis
Background For large vessel occlusion (LVO) ischemic strokes, three major techniques of mechanical thrombectomy (MT) have demonstrated efficacy. Here we compare the safety and efficacy of stent retrievers (SR), contact aspiration (Asp), and a combined mechanical thrombectomy (cMT) for LVO ischemic stroke. Methods Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we queried the PubMed, EMBASE, Scopus, and Web of Science databases for studies published prior to December 2024 describing patients with ischemic stroke who underwent MT using SR, Asp, or cMT. Results Twnety-four studies comprising a total of 12 845 patients were included in the analysis. Compared with cMT, Asp was associated with a lower rate of first pass effect (FPE) (risk ratio (RR) 0.67; 95% CI 0.46 to 0.96), shorter procedure duration (mean difference (MD) −13.35 min; 95% CI −20.83 to –5.87), and lower risk of arterial dissection (RR 0.50; 95% CI 0.29 to 0.87). Additionally, SR use was linked to a higher procedure duration compared with Asp (MD 13.39 min; 95% CI 5.55 to 21.22) and a lower symptomatic intracranial hemorrhage rate (RR 0.75; 95% CI 0.59 to 0.96). No significant differences were observed between groups in terms of number of passes, successful recanalization, 90-day functional outcomes, mortality, arterial perforation, or embolization to new territory. Conclusions All three techniques demonstrated similar recanalization rates and functional outcomes. However, Asp was associated with shorter procedure times and fewer arterial dissection complications, while cMT showed a higher FPE. Given the comparable overall efficacy, the choice of technique should be guided by the physician’s preference, expertise, and confidence, tailored to the individual patient’s profile.
- 11 August 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 31 (1) , 1-8
Single-Session Middle Meningeal Artery Embolization With Concomitant Evacuation Surgery for Chronic Subdural Hematoma: Impact of Surgical Approach
BACKGROUND AND OBJECTIVES: Single-session middle meningeal artery embolization (MMAE) combined with surgical evacuation is a rapidly emerging strategy in the treatment of chronic subdural hematoma (cSDH). However, the effect of different evacuation techniques within this approach remains unclear. METHODS: We conducted a retrospective multicenter cohort study across 8 US institutions of patients with cSDH who underwent single-session MMAE with concomitant surgical evacuation between 2018 and 2024. Surgical techniques were categorized as craniotomy or burr-hole evacuation (twist drill, electric drill, or subdural evacuating port systems). Primary outcomes included procedural time, adverse events, and early clinical outcomes. RESULTS: The 205 included patients (30.2% female) underwent 276 procedures (35 craniotomies, 241 burr-hole evacuations). The median patient age was 75 years, and 157 (76.6%) patients were functionally independent at baseline. Subdural characteristics were similar in the craniotomy (n = 26) and the burr-hole evacuation (n = 179) groups. Patients who underwent craniotomy had longer drainage durations ( P < .001) and longer operative times (209 vs 190 min, P = .015). Patients undergoing craniotomy were also less likely to be discharged by postoperative day 6 ( P = .040). Procedural mortality rates were low overall (0.4%) and did not differ significantly between groups. Early postoperative mortality rates (3.3% overall) were also comparable across both groups. Overall mortality was higher in craniotomy patients (34.3% vs 10.4%, adjusted odds ratio = 3.69; 95% confidence interval: 1.23-11.06; P = .019), mainly because of late mortality and not attributable to the index procedure. CONCLUSION: In this multicenter study of single-session MMAE with concomitant evacuation for cSDH, burr-hole–based techniques were associated with shorter operative times and with postprocedural patterns such as earlier drain removal, which correlated with earlier discharge. These findings support the preferential use of minimally invasive evacuation methods within the single-session paradigm when anatomically and technically appropriate.
- 11 August 2025
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 31 (1) , 1-8
Single-Session Middle Meningeal Artery Embolization With Concomitant Evacuation Surgery for Chronic Subdural Hematoma: Impact of Surgical Approach
BACKGROUND AND OBJECTIVES: Single-session middle meningeal artery embolization (MMAE) combined with surgical evacuation is a rapidly emerging strategy in the treatment of chronic subdural hematoma (cSDH). However, the effect of different evacuation techniques within this approach remains unclear. METHODS: We conducted a retrospective multicenter cohort study across 8 US institutions of patients with cSDH who underwent single-session MMAE with concomitant surgical evacuation between 2018 and 2024. Surgical techniques were categorized as craniotomy or burr-hole evacuation (twist drill, electric drill, or subdural evacuating port systems). Primary outcomes included procedural time, adverse events, and early clinical outcomes. RESULTS: The 205 included patients (30.2% female) underwent 276 procedures (35 craniotomies, 241 burr-hole evacuations). The median patient age was 75 years, and 157 (76.6%) patients were functionally independent at baseline. Subdural characteristics were similar in the craniotomy (n = 26) and the burr-hole evacuation (n = 179) groups. Patients who underwent craniotomy had longer drainage durations ( P < .001) and longer operative times (209 vs 190 min, P = .015). Patients undergoing craniotomy were also less likely to be discharged by postoperative day 6 ( P = .040). Procedural mortality rates were low overall (0.4%) and did not differ significantly between groups. Early postoperative mortality rates (3.3% overall) were also comparable across both groups. Overall mortality was higher in craniotomy patients (34.3% vs 10.4%, adjusted odds ratio = 3.69; 95% confidence interval: 1.23-11.06; P = .019), mainly because of late mortality and not attributable to the index procedure. CONCLUSION: In this multicenter study of single-session MMAE with concomitant evacuation for cSDH, burr-hole–based techniques were associated with shorter operative times and with postprocedural patterns such as earlier drain removal, which correlated with earlier discharge. These findings support the preferential use of minimally invasive evacuation methods within the single-session paradigm when anatomically and technically appropriate.
- Open Access
- 7 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3247
Impact of Frailty and Other Factors as Estimated by HU to Predict Response to Anabolic Bone Medications
Introduction: Bone health optimization is a key component of the preoperative management of spine surgery patients, as poor bone quality increases the odds of mechanical complications. The present study aimed to achieve the following: (1) compare the relative efficacy of current osteoporosis medications in improving bone quality; (2) identify factors influencing treatment response in preoperative spine surgery patients. Methods: Patients treated at a single, multisite institution who received osteoporosis treatment were identified. Data were gathered on pre- and post-treatment lumbar spine Hounsfield Unit (HU) measurements, patient demographics, frailty scores (modified Frailty Index/mFI, risk analysis index/RAI), and pharmacologic treatment details. The primary outcome was a ≥7 point improvement in lumbar HU, and baseline and logistic regression models were utilized to identify factors associated with this improvement. Medications were grouped as anabolic (teriparatide, romosozumab) and antiresorptive (denosumab, alendronate) therapies. Results: A total of 267 patients were included (median age: 74 years; IQR [66–81]; 67.3% female), with 127 (47.6%) improving by ≥7 HU. The treatment agents used were alendronate (95), denosumab (113), romosozumab (31), and teriparatide (28). Univariable comparisons revealed significant differences across medication groups in age (p < 0.001), sex (p < 0.001), mFI (p < 0.001), RAI (p = 0.004), BMI (p < 0.001), pre-treatment HU (p = 0.022), and treatment duration (p < 0.001). The highest HU improvement rates (ΔHU ≥ 7) were observed in patients receiving the anabolic medications romosozumab (67.7%) and teriparatide (60.7%). Univariable logistic regression identified male sex (OR 0.54, p = 0.019), higher pre-treatment HU (OR 0.99, p = 0.006), and longer treatment duration (OR 0.97, p = 0.003) as factors associated with lower odds of HU improvement. Only romosozumab was associated with significantly higher odds of HU improvement relative to alendronate (OR 3.02, p = 0.012). In our multivariable analysis, male sex (OR 0.53, p = 0.028) and higher pre-treatment HU (OR 0.99, p = 0.002) remained significant predictors of HU improvement. However, medication type was not significant in the multivariable analysis. Conclusions: Our study highlights that male sex and higher pre-treatment HU were independently associated with lower odds of HU improvement, while medication type was not a significant predictor. Additionally, anabolic agents offered superior improvement relative to antiresorptive therapies.
- 7 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (9) , 3247
Open AccessImpact of Frailty and Other Factors as Estimated by HU to Predict Response to Anabolic Bone Medications
Introduction: Bone health optimization is a key component of the preoperative management of spine surgery patients, as poor bone quality increases the odds of mechanical complications. The present study aimed to achieve the following: (1) compare the relative efficacy of current osteoporosis medications in improving bone quality; (2) identify factors influencing treatment response in preoperative spine surgery patients. Methods: Patients treated at a single, multisite institution who received osteoporosis treatment were identified. Data were gathered on pre- and post-treatment lumbar spine Hounsfield Unit (HU) measurements, patient demographics, frailty scores (modified Frailty Index/mFI, risk analysis index/RAI), and pharmacologic treatment details. The primary outcome was a ≥7 point improvement in lumbar HU, and baseline and logistic regression models were utilized to identify factors associated with this improvement. Medications were grouped as anabolic (teriparatide, romosozumab) and antiresorptive (denosumab, alendronate) therapies. Results: A total of 267 patients were included (median age: 74 years; IQR [66–81]; 67.3% female), with 127 (47.6%) improving by ≥7 HU. The treatment agents used were alendronate (95), denosumab (113), romosozumab (31), and teriparatide (28). Univariable comparisons revealed significant differences across medication groups in age (p < 0.001), sex (p < 0.001), mFI (p < 0.001), RAI (p = 0.004), BMI (p < 0.001), pre-treatment HU (p = 0.022), and treatment duration (p < 0.001). The highest HU improvement rates (ΔHU ≥ 7) were observed in patients receiving the anabolic medications romosozumab (67.7%) and teriparatide (60.7%). Univariable logistic regression identified male sex (OR 0.54, p = 0.019), higher pre-treatment HU (OR 0.99, p = 0.006), and longer treatment duration (OR 0.97, p = 0.003) as factors associated with lower odds of HU improvement. Only romosozumab was associated with significantly higher odds of HU improvement relative to alendronate (OR 3.02, p = 0.012). In our multivariable analysis, male sex (OR 0.53, p = 0.028) and higher pre-treatment HU (OR 0.99, p = 0.002) remained significant predictors of HU improvement. However, medication type was not significant in the multivariable analysis. Conclusions: Our study highlights that male sex and higher pre-treatment HU were independently associated with lower odds of HU improvement, while medication type was not a significant predictor. Additionally, anabolic agents offered superior improvement relative to antiresorptive therapies.
- Open Access
Advances in the Repurposing and Blood–Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors
Central nervous system (CNS) tumors are the leading cause of cancer-related mortality in children, with prognosis remaining dismal for some of these malignancies. Though the past two decades have seen advancements in surgery, radiation, and targeted therapy, major unresolved hurdles continue to undermine the therapeutic efficacy. These include challenges in suboptimal drug delivery through the blood–brain barrier (BBB), marked intra-tumoral molecular heterogeneity, and the elusive tumor microenvironment. Drug repurposing or re-tasking FDA-approved drugs with evidence of penetration into the CNS, using newer methods of intracranial drug delivery facilitating optimal drug exposure, has been an area of intense research. This could be a valuable tool, as most of these agents have already gone through the lengthy process of drug development and the evaluation of safety risks and the optimal pharmacokinetic profile. They can now be used and tested in clinics with an accelerated and different approach. Conclusions: The next-generation therapeutic strategy should prioritize repurposing oncologic and non-oncologic drugs that have been used for other indication, and have demonstrated robust preclinical activity against pediatric brain tumors. In combination with novel drug delivery techniques, these drugs could hold significant therapeutic promise in pediatric neurooncology.
Open AccessAdvances in the Repurposing and Blood–Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors
Central nervous system (CNS) tumors are the leading cause of cancer-related mortality in children, with prognosis remaining dismal for some of these malignancies. Though the past two decades have seen advancements in surgery, radiation, and targeted therapy, major unresolved hurdles continue to undermine the therapeutic efficacy. These include challenges in suboptimal drug delivery through the blood–brain barrier (BBB), marked intra-tumoral molecular heterogeneity, and the elusive tumor microenvironment. Drug repurposing or re-tasking FDA-approved drugs with evidence of penetration into the CNS, using newer methods of intracranial drug delivery facilitating optimal drug exposure, has been an area of intense research. This could be a valuable tool, as most of these agents have already gone through the lengthy process of drug development and the evaluation of safety risks and the optimal pharmacokinetic profile. They can now be used and tested in clinics with an accelerated and different approach. Conclusions: The next-generation therapeutic strategy should prioritize repurposing oncologic and non-oncologic drugs that have been used for other indication, and have demonstrated robust preclinical activity against pediatric brain tumors. In combination with novel drug delivery techniques, these drugs could hold significant therapeutic promise in pediatric neurooncology.
- Open Access
- 6 July 2005
- Published by Oxford University Press (OUP) in Journal of Public Health
- Vol. 27 (3) , 270-275
An investigation into GPs with high patient mortality rates: a retrospective study
Background As part of the work of the Shipman Inquiry, five general practitioners (GPs) in West Sussex were identified as having excessively high mortality rates. The aim of this study was to identify reasons for the higher-than-expected mortality rates of these five GPs. Methods A retrospective analysis was made of routine mortality and patient registration data from primary-care practices in West Sussex, and the case notes of deceased patients were reviewed. Outcome measures included standardized mortality ratios (SMRs), proportion of deaths in nursing homes, and reviewers’ concordance with GP decisions to issue a death certificate. Results The high death rates were not explained by the age and sex composition of each GP’s patient population. SMRs ranged from 145 to 239 (average for West Sussex = 100) and all differences from the West Sussex average were statistically significant (p p = 0.015). Analysis of 153 deceased patients’ notes revealed no evidence of poor clinical practice. In 114 cases, at least one independent reviewer agreed with the decision to issue a death certificate. In the remaining 39 (25 per cent) cases, inadequate information in the patient’s record explained the reviewers’ uncertainty about issuing a certificate. Conclusion A proportionately high registration of nursing home residents is the most likely explanation for the excessive mortality rates of these five GPs. This investigation was time-consuming and costly, and highlights the potential ramifications for primary-care organizations of introducing a national system for monitoring death rates in primary care.
- 6 July 2005
- Published by Oxford University Press (OUP) in Journal of Public Health
- Vol. 27 (3) , 270-275
Open AccessAn investigation into GPs with high patient mortality rates: a retrospective study
Background As part of the work of the Shipman Inquiry, five general practitioners (GPs) in West Sussex were identified as having excessively high mortality rates. The aim of this study was to identify reasons for the higher-than-expected mortality rates of these five GPs. Methods A retrospective analysis was made of routine mortality and patient registration data from primary-care practices in West Sussex, and the case notes of deceased patients were reviewed. Outcome measures included standardized mortality ratios (SMRs), proportion of deaths in nursing homes, and reviewers’ concordance with GP decisions to issue a death certificate. Results The high death rates were not explained by the age and sex composition of each GP’s patient population. SMRs ranged from 145 to 239 (average for West Sussex = 100) and all differences from the West Sussex average were statistically significant (p p = 0.015). Analysis of 153 deceased patients’ notes revealed no evidence of poor clinical practice. In 114 cases, at least one independent reviewer agreed with the decision to issue a death certificate. In the remaining 39 (25 per cent) cases, inadequate information in the patient’s record explained the reviewers’ uncertainty about issuing a certificate. Conclusion A proportionately high registration of nursing home residents is the most likely explanation for the excessive mortality rates of these five GPs. This investigation was time-consuming and costly, and highlights the potential ramifications for primary-care organizations of introducing a national system for monitoring death rates in primary care.